睡眠质量和临床前心力衰竭的结果:英国生物库前性队列研究
Fang Zhu1, Joseph J Shearer1, Jungnam Joo2
1Epidemiology and Community Health Branch, National Heart, Lung, and Blood Institute.
The American journal of medicine
|June 4, 2025
概括
睡眠质量差显著增加患临床心力衰竭 (HF) 和死亡率的风险,特别是在女性中. 在临床前HF患者解决睡眠问题可能会改善结果.
科学领域:
- 心脏病学 心脏病学
- 睡眠医学 睡眠医学
- 公共卫生 公共卫生
背景情况:
- 预防心力衰竭对于降低发病率和死亡率至关重要.
- 目前的指导方针侧重于HF的进展,但睡眠对临床前HF结果的影响尚不清楚.
- 这项研究研究了临床前HF的睡眠质量及其与临床HF和死亡率的关联.
研究的目的:
- 检查一大批患有临床前心力衰竭 (A/B阶段) 个体的睡眠质量.
- 评估各种睡眠特征与患临床心力衰竭 (C/D阶段) 或死亡的风险之间的关联.
- 探索睡眠质量对临床结果在临床前HF患者的影响.
主要方法:
- 利用英国生物库数据 (2006-2010) 识别了311,446名临床前高血压患者.
- 评估自我报告的睡眠时间,时间型,失眠,打和白天嗜睡,创建睡眠质量评分.
- 采用具有竞争风险的Cox比例危险模型来分析与临床HF和死亡率的关联,在中位数为12年的随访期间.
主要成果:
- 在5%的参与者中观察到睡眠质量差,并且与女性 (HR 2.03) 和男性 (HR 1.55) 临床HF风险增加有关.
- 在所有睡眠质量类别中,高血压风险与睡眠剥夺有关 (P < .01).
- 在随访期间,发生了超过10,780例临床HF事件和24,996例死亡.
结论:
- 低睡眠质量在临床前心力衰竭中普遍存在,并显著提高了进展到临床心力衰竭和死亡率的风险.
- 患有临床前HF和睡眠质量差的女性的风险特别高.
- 针对临床前HF人群的睡眠质量的干预措施,特别是那些面临贫困的人群,可以减轻不良结果.
相关概念视频
Heart Failure II: Pathophysiology
59
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
59
Heart Failure III: Clinical Manifestations
60
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
60
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
355
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
355
Heart Failure I: Introduction
79
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
79
Pathophysiology of Heart Failure
1.9K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.9K
Heart Failure VII: Nursing Interventions
147
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
147


